首页> 外文会议>Conference on Medical Imaging : Biomedical Applications in Molecular, Structural, and Functional Imaging >Classification of skin-cancer lesions based on Fluorescence Lifetime Imaging
【24h】

Classification of skin-cancer lesions based on Fluorescence Lifetime Imaging

机译:基于荧光寿命成像的皮肤癌病变分类

获取原文

摘要

Every year more than 5.4 million new cases of skin cancer are reported in the US. Melanoma is the most lethal type withonly 5% occurrence rate, but accounts for over 75% of all skin cancer deaths. Non-melanoma skin cancer, especially basalcell carcinoma (BCC) is the most commonly occurring and often curable type that affects more than 3 million people andcauses about 2000 deaths in the US annually. The current diagnosis involves visual inspection, followed by biopsy of thelesions. The major drawbacks of this practice include difficulty in border detection causing incomplete treatment and, theinability to distinguish between clinically similar lesions. Melanoma is often mistaken for the benign lesion pigmentedseborrheic keratosis (pSK), making it extremely important to differentiate benign and malignant lesions. In this work, anovel feature extraction algorithm based on phasors was performed on the Fluorescence Lifetime Imaging (FLIM) imagesof the skin to reliably distinguish between benign and malignant lesions. This approach, unlike the standard FLIM dataprocessing method that requires time-deconvolution of the instrument response from the measured time-resolvedfluorescence signal, is computationally much simpler and provides a unique set of features for classification. Subsequently,FLIM derived features were selected using a double step cross validation approach that assesses the reliability and theperformance of the resultant trained classifier. Promising FLIM-based classification performance was attained fordetecting benign from malignant pigmented (sensitivity: ~80%, specificity: 79%, overall accuracy: ~79%) and nonpigmented(sensitivity: ~88%, specificity: 83%, overall accuracy: ~87%) lesions.
机译:每年在美国报告超过540万案的皮肤癌。黑色素瘤是最致命的类型只有5%的发生率,但占所有皮肤病死亡的75%以上。非黑色素瘤皮肤癌,尤其是基础细胞癌(BCC)是最常见的,通常的可固化类型,影响超过300万人每年导致美国约2000人死亡。目前的诊断涉及目视检查,然后是活检病变。这种做法的主要缺点包括边境检测难度导致待遇不完整,无法区分临床上类似的病变。黑色素瘤经常被误认为是色素的良性病变Seborrheic角化症(PSK),使其极为重要的是区分良性和恶性病变。在这项工作中,一个基于相量的新型特征提取算法在荧光寿命成像(FLIM)图像上进行皮肤可靠地区分良性和恶性病变。与标准FLIM数据不同,这种方法从测量的时间分辨地,需要时间去折叠的处理方法荧光信号,是计算方式更简单,并提供了一组独特的分类功能。随后,使用双步交叉验证方法选择flim推导特征,评估可靠性和可靠性结果培训分类器的性能。获得了有希望的基于Flim的分类性能从恶性色素沉积(敏感性:〜80%,特异性:79%,总体准确性:〜79%)和非差异(敏感性:〜88%,特异性:83%,总体精度:〜87%)病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号